GA-Prostanal in Brief
GA-Prostanal now pass registration at the Pharmacological Committee of the Ministry of Health and Social Affairs of Georgia.
GA-Prostanal has passed preclinical and clinical trials in following organizations:
GA-Prostanal is recommended for the treatment of chronic banal prostatitis.
GA-Prostanal is a standardized combination of peptides identified from ecologically pure raw materials of plant origin (Know-how), by biochemical and chromatographically methods. In medical practice it is used as colorless injection solution.
The clinical trials of GA- Prostanal showed that it is almost safe preparation. Its reception improves urination process, considerably reduces the disuric phenomena and has positive impact on improvement of quality of life. In a number of patients preparation reception also improves ejaculation. The specified influence is possible to explain by impact of a preparation on the developments of stagnation, caused in prostate iron a syndrome of a congestion of a hip and positive influence on inflammatory processes. The clinical studying of GA- PROSTANAL and demand carrying out further deeper research, and on the basis of results of the research carried out by us we already can judge an essential contribution in prostatitis treatment. Together with the obtained data of the clinical research, the fact established by preclinical researches the strong immunotropny influence of GA- Prostanal and on immune system of an organism is considerable. In particular, it possesses ability of activation of macrophages, neutrophils and cytotoxic cells. It is known that these links of immunity are responsible for antimicrobic activity, for phagocytosis the infected and damaged cells, for use as construction material of a number of products of disintegration in an organism and/or their elimination from an organism. As it is known from the prostatitis etiology, one of important factors of an origin and development of this disease are inflammatory processes caused by microbes.
GA-Prostanal has passed preclinical and clinical trials in following organizations:
- JSC National Center of Urology, Tbilisi, Georgia.
- Clinical and Experimental Research Institute of Tbilisi State Medical University;
- Medical & Biological Scientific Research Centre – Company <<Alexis>>;
- Laboratory of Cell Signal Mechanisms of the I.Paladin Institute of Biochemistry at Ukrainian Medical Academy;
- Medical Research Institute of Physical Chemistry at the Ministry of Healthcare of Russian Federation;
- Pharmacological Department of the Medical University of Russian Federation;
- Fuji Memorial Institute of the Preclinical Research, Bivako/Japan;
- Tokushima Otsuka Immunology Research Institute, Japan;
- Tokushima Institute of New Drug Research and Safety Evaluation, Japan;
GA-Prostanal is recommended for the treatment of chronic banal prostatitis.
GA-Prostanal is a standardized combination of peptides identified from ecologically pure raw materials of plant origin (Know-how), by biochemical and chromatographically methods. In medical practice it is used as colorless injection solution.
The clinical trials of GA- Prostanal showed that it is almost safe preparation. Its reception improves urination process, considerably reduces the disuric phenomena and has positive impact on improvement of quality of life. In a number of patients preparation reception also improves ejaculation. The specified influence is possible to explain by impact of a preparation on the developments of stagnation, caused in prostate iron a syndrome of a congestion of a hip and positive influence on inflammatory processes. The clinical studying of GA- PROSTANAL and demand carrying out further deeper research, and on the basis of results of the research carried out by us we already can judge an essential contribution in prostatitis treatment. Together with the obtained data of the clinical research, the fact established by preclinical researches the strong immunotropny influence of GA- Prostanal and on immune system of an organism is considerable. In particular, it possesses ability of activation of macrophages, neutrophils and cytotoxic cells. It is known that these links of immunity are responsible for antimicrobic activity, for phagocytosis the infected and damaged cells, for use as construction material of a number of products of disintegration in an organism and/or their elimination from an organism. As it is known from the prostatitis etiology, one of important factors of an origin and development of this disease are inflammatory processes caused by microbes.
Download Pdf Version |
|
Download Microsoft Word Version |
|